The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer
Open accessAbstract
BACKGROUND: Breast-conservation therapy for early-stage breast cancer is now an accepted treatment, but there is still controversy about its comparability with mastectomy. Between 1979 and 1987, the National Cancer Institute conducted a randomized, single-institution trial comparing lumpectomy, axillary dissection, and radiation with mastectomy and axillary dissection for stage I and II breast cancer. We update the results of that trial after a median potential follow-up of 10.1 years. METHODS: Two hundred forty-seven patients with clinical stage I and II breast cancer were randomly assigned to undergo either modified radical mastectomy or lumpectomy, axillary dissection, and radiation therapy. The 237 patients who actually underwent randomization have been followed for a median of 10.1 years. The primary end points were overall survival and disease-free survival. RESULTS: At 10 years overall survival was 75 percent for the patients assigned to mastectomy and 77 percent for those assigned to lumpectomy plus radiation (P = 0.89). Disease-free survival at 10 years was 69 percent for the patients assigned to mastectomy and 72 percent for those assigned to lumpectomy plus radiation (P = 0.93). The rate of local regional recurrence at 10 years was 10 percent after mastectomy and 5 percent after lumpectomy plus radiation (P = 0.17) after recurrences successfully treated by mastectomy were censored from the analysis. CONCLUSIONS: In the management of stage I and II breast cancer, breast conservation with lumpectomy and radiation offers results at 10 years that are equivalent to those with mastectomy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Breast-conserving surgery combined with radiation therapy is standard treatment for early stage breast cancer and provides equivalent survival to mastectomy [20-27].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [24]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,897
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L., Fisher, E., Deutsch, M., Caplan, R., Pilch, Y., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201302 · Cited by 1,587
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.2307/2282717 · Cited by 1,144
Sarrazin, D., Lê, M. G., Arriagada, R., Contesso, G., Fontaine, F., Spielmann, M., Rochard, F., Le Chevalier, T., & Lacour, J. (1989) · Radiotherapy and Oncology · doi:10.1016/0167-8140(89)90165-5 · Cited by 561
Significance of ipsilateral breast tumour recurrence after lumpectomy
Fisher, B., Anderson, S., Fisher, E. R., Redmond, C., Wickerham, D. L., Wolmark, N., Mamounas, E. P., Deutsch, M., & Margolese, R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90475-5 · Cited by 556
Veronesi, U., Banfi, A., Salvadori, B., Luini, A., Saccozzi, R., Zucali, R., Marubini, E., Del Vecchio, M., Boracchi, P., Marchini, S., et al. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90113-8 · Cited by 493
Lichter, A. S., Lippman, M. E., Danforth, D. N., d'Angelo, T., Steinberg, S. M., deMoss, E., MacDonald, H. D., Reichert, C. M., Merino, M., & Swain, S. M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.976 · Cited by 347
Self-citation
Research works printed but not linked: 6
- van Dongen JA, 1992, Monogr Natl Cancer Inst, 11, 15
- Blichert-Toft M, 1992, Monogr Natl Cancer Inst, 11, 19
- Straus K, 1992, Monogr Natl Cancer Inst, 11, 27
- Lippman ME, 1986, Monogr Natl Cancer Inst, 1, 99
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
- 10.1002/1097-0142(19891201)64:11<2217::AID-CNCR2820641106>3.0.CO;2-2 · doi:10.1002/1097-0142(19891201)64:11<2217::aid-cncr2820641106>3.0.co;2-2
Cited by
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
van Dongen, J. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1143 · Cited by 1,271
Bartelink, H., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W. J., Oei, S. B., Wárlám-Rodenhuis, C. C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4991 · Cited by 1,047
Arriagada, R., Lê, M. G., Rochard, F., & Contesso, G. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1558 · Cited by 612
Oncoplastic Techniques Allow Extensive Resections for Breast-Conserving Therapy of Breast Carcinomas
Clough, K. B., Lewis, J. S., Couturaud, B., Fitoussi, A., Nos, C., & Falcou, M.-C. (2003) · Annals of Surgery · doi:10.1097/00000658-200301000-00005 · Cited by 608
Metadata
- Authors
- Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- University of Michigan (US)
- Georgetown University (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1995-04-06
- Volume
- 332
- Issue
- 14
- Pages
- 907-911
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1982623790
- Cited by
- 892
- References
- 23
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 12 · 2023: 21 · 2022: 25 · 2021: 22 · 2020: 27 · 2019: 14 · 2018: 16 · 2017: 25 · 2016: 23 · 2015: 24 · 2014: 31 · 2013: 29 · 2012: 38
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- breast-conserving therapy, breast-conserving surgery, mastectomy, early breast cancer, axillary lymph node dissection, radiotherapy, overall survival, disease-free survival, local recurrence, long-term follow-up
- MeSH terms
- Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymph Node Excision, Mastectomy, Modified Radical, Mastectomy, Segmental, Chemotherapy, Adjuvant, Treatment Failure, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer. https://app.cochat.ai/papers/10.1056/nejm199504063321402
- The paper
- Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995). Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejm199504063321402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.